Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Will US FDA Wind Up With More Political Positions Under Trump?

Executive Summary

Incoming administration could appoint key legal and policy positions to shape agenda’s agenda.

You may also be interested in...



A Burning FDA Hiring Freeze Question: What About User Fee-Supported Staff?

Industry worries about user fee programs as US FDA could wait weeks before finding out how President Trump's hiring freeze affects it.

A Burning FDA Hiring Freeze Question: What About User-Fee-Supported Staff?

Industry worries about user fee programs as US FDA could wait weeks before finding out how President Trump's hiring freeze affects it.

Trump Takes Office, Change At US FDA Arrives With ‘Beachhead Teams’

Incoming president will not hold over any FDA political appointees from the Obama administration, but what exactly his stamp on the agency will be remains unclear.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS119618

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel